313 related articles for article (PubMed ID: 31461640)
1. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
[TBL] [Abstract][Full Text] [Related]
2. BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration.
Garceau D; Chauret N
Pulm Pharmacol Ther; 2019 Jun; 56():56-62. PubMed ID: 30902655
[TBL] [Abstract][Full Text] [Related]
3. A hydrophobic residue in position 15 of the rP2X3 receptor slows desensitization and reveals properties beneficial for pharmacological analysis and high-throughput screening.
Hausmann R; Bahrenberg G; Kuhlmann D; Schumacher M; Braam U; Bieler D; Schlusche I; Schmalzing G
Neuropharmacology; 2014 Apr; 79():603-15. PubMed ID: 24452010
[TBL] [Abstract][Full Text] [Related]
4. Flexible subunit stoichiometry of functional human P2X2/3 heteromeric receptors.
Kowalski M; Hausmann R; Schmid J; Dopychai A; Stephan G; Tang Y; Schmalzing G; Illes P; Rubini P
Neuropharmacology; 2015 Dec; 99():115-30. PubMed ID: 26184350
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of P2X1, P2X2, P2X3, and P2X4 receptor subunits in rat nodose ganglion neurons.
Wang L; Feng D; Yan H; Wang Z; Pei L
PLoS One; 2014; 9(5):e96699. PubMed ID: 24798490
[TBL] [Abstract][Full Text] [Related]
6. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T
Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577
[TBL] [Abstract][Full Text] [Related]
7. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
De Roo M; Boué-Grabot E; Schlichter R
Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
[TBL] [Abstract][Full Text] [Related]
8. The P2X3 antagonist P1, P5-di[inosine-5'] pentaphosphate binds to the desensitized state of the receptor in rat dorsal root ganglion neurons.
Ford KK; Matchett M; Krause JE; Yu W
J Pharmacol Exp Ther; 2005 Oct; 315(1):405-13. PubMed ID: 16014755
[TBL] [Abstract][Full Text] [Related]
9. Modulatory activity of extracellular H+ and Zn2+ on ATP-responses at rP2X1 and rP2X3 receptors.
Wildman SS; King BF; Burnstock G
Br J Pharmacol; 1999 Sep; 128(2):486-92. PubMed ID: 10510462
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Potent Antiallodynic Agents for Neuropathic Pain Targeting P2X3 Receptors.
Jung YH; Kim YO; Lin H; Cho JH; Park JH; Lee SD; Bae J; Kang KM; Kim YG; Pae AN; Ko H; Park CS; Yoon MH; Kim YC
ACS Chem Neurosci; 2017 Jul; 8(7):1465-1478. PubMed ID: 28323403
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels.
Ase AR; Honson NS; Zaghdane H; Pfeifer TA; Séguéla P
Mol Pharmacol; 2015 Apr; 87(4):606-16. PubMed ID: 25597706
[TBL] [Abstract][Full Text] [Related]
12. P2X1 and P2X2 receptors in the central nervous system as possible drug targets.
Hausmann R; Schmalzing G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):675-86. PubMed ID: 22963438
[TBL] [Abstract][Full Text] [Related]
13. A317491 relieved HIV gp120-associated neuropathic pain involved in P2X
Yi Z; Rao S; Ouyang S; Bai Y; Yang J; Ma Y; Han X; Wu B; Zou L; Jia T; Zhao S; Hu X; Lei Q; Gao Y; Liu S; Xu H; Zhang C; Liang S; Li G
Brain Res Bull; 2017 Apr; 130():81-89. PubMed ID: 28065732
[TBL] [Abstract][Full Text] [Related]
14. Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists.
Tian M; Abdelrahman A; Baqi Y; Fuentes E; Azazna D; Spanier C; Densborn S; Hinz S; Schmid R; Müller CE
J Med Chem; 2020 Jun; 63(11):6164-6178. PubMed ID: 32345019
[TBL] [Abstract][Full Text] [Related]
15. Distribution of P2X1, P2X2, and P2X3 receptor subunits in rat primary afferents: relation to population markers and specific cell types.
Petruska JC; Cooper BY; Gu JG; Rau KK; Johnson RD
J Chem Neuroanat; 2000 Nov; 20(2):141-62. PubMed ID: 11118807
[TBL] [Abstract][Full Text] [Related]
16. Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating.
Sivcev S; Slavikova B; Ivetic M; Knezu M; Kudova E; Zemkova H
J Steroid Biochem Mol Biol; 2020 Sep; 202():105725. PubMed ID: 32652201
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
Kim YC; Brown SG; Harden TK; Boyer JL; Dubyak G; King BF; Burnstock G; Jacobson KA
J Med Chem; 2001 Feb; 44(3):340-9. PubMed ID: 11462975
[TBL] [Abstract][Full Text] [Related]
18. Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation.
Richards D; Gever JR; Ford AP; Fountain SJ
Br J Pharmacol; 2019 Jul; 176(13):2279-2291. PubMed ID: 30927255
[TBL] [Abstract][Full Text] [Related]
19. Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications.
Marucci G; Dal Ben D; Buccioni M; Martí Navia A; Spinaci A; Volpini R; Lambertucci C
Expert Opin Ther Pat; 2019 Dec; 29(12):943-963. PubMed ID: 31726893
[No Abstract] [Full Text] [Related]
20. Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies.
Shcherbatko A; Foletti D; Poulsen K; Strop P; Zhu G; Hasa-Moreno A; Melton Witt J; Loo C; Krimm S; Pios A; Yu J; Brown C; Lee JK; Stroud R; Rajpal A; Shelton D
J Biol Chem; 2016 Jun; 291(23):12254-70. PubMed ID: 27129281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
